Skip to content
Medical Health Aged Care

Congratulating RACGP national award winners

Royal Australian College of GPs 3 mins read

The Royal Australian College of General Practitioners (RACGP) is congratulating this year’s national RACGP Award winners.

 

This year, the winners are receiving their awards ahead of the WONCA World Conference Sydney 2023.

 

WONCA 2023 is being hosted by the Royal Australian College of General Practitioners (RACGP) – bringing one of the largest global conferences for GPs to Australia for the first time in over 20 years.

 

RACGP’s national award winners:

  • the prestigious Rose Hunt Award has gone to Dr Christopher Hughes from Tasmania
  • the Corlis Medical Educator Award has gone to Dr Danielle James from Queensland
  • the GP of the Year Award has gone to Dr Richard Draper from New South Wales
  • the GP Supervisor of the Year Award has gone to Dr Kate Manderson from New South Wales
  • the GP in Training of the Year Award has gone to Dr Corey Dalton from Western Australia
  • the General Practice of the Year Award has gone to Banksia Medical Centre in Victoria
  • the Brian Williams Award, which acknowledges medical practitioners whose mentoring and support enables rural GPs to safely dedicate themselves to their communities, has gone to Professor Ross Wilson in New South Wales
  • the Rural Registrar of the Year Award goes to Dr Ishani Kaluthotage (South Australia) and Dr Dean McKittrick (Western Australia)
  • the Medical Student Bursary award has gone to Janelle Wong of the Northern Territory
  • the Standing Strong Together Award, which is given to an RACGP member who has worked together with an Aboriginal and/or Torres Strait Islander person or community group to improve health outcomes for Aboriginal and Torres Strait Islander people, has gone to Dr Kali Hayward (South Australia) and Dr Mark Daley (Victoria)
  • the Growing Strong Award, which is given to an Aboriginal and/or Torres Strait Islander GP in training who demonstrates a commitment to giving back to the community, has gone to Dr Patrick McNamara of the Northern Territory
  • the Medical Student Bursary Award, which is given to an Aboriginal and/or Torres Strait Islander medical student who has an interest in Aboriginal and Torres Strait Islander health and pursuing a career in general practice, has gone to Loyola Wills from South Australia.

 

RACGP President Dr Nicole Higgins congratulated this year’s winners.

 

“These award winners should be tremendously proud. The RACGP Awards highlight why GPs and practice teams are so important to the communities right across Australia,” she said.

 

“This year’s winners presented at the outstanding WONCA conference in Sydney are an inspiration to GPs, GPs in training and future doctors everywhere, so congratulations to you all. If you are considering a career in general practice, I encourage you to look to these individuals – they demonstrate why it is such a rewarding and interesting career.”

 

The WONCA 2023 conference theme is “Recovery, reconnection, and revival. A celebration of primary care.” This year’s conference includes more than 800 presentations and workshops from over 700 local and international presenters from around the world, and over 50 topic streams, including health reform, mental health, women’s health, climate change, rural practice, and more.

 

~ENDS

RACGP spokespeople and award winners are available for interview.


About us:

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Media Adviser

Ally Francis
Media Adviser

Stuart Winthrope
Media Officer

Contact: 03 8699 0992media@racgp.org.au

Follow us on Twitter: @RACGP and Facebook.

Media

More from this category

  • Medical Health Aged Care
  • 31/10/2024
  • 17:55
Kyowa Kirin Co., Ltd.

Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company

Masashi Miyamoto to be named Chairman and CEO Abdul Mullick to be named President and COO Changes designed to further deliver on company’s 2030…

  • Contains:
  • Medical Health Aged Care
  • 31/10/2024
  • 12:10
MannKind

First Site Initiated in Australia for MannKind’s Phase 3 Clinical Trial Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease

ICoN-1 study presentation planned November 1 at NTM Symposium AustraliaStudy is cleared by health authorities to proceed in Australia, U.S., Japan and South Korea, with Taiwan anticipated by end of year DANBURY, Conn., Oct. 30, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that it has initiated its first site for its Phase 3 clinical trial evaluating efficacy and safety of Clofazimine Inhalation Suspension for the treatment of nontuberculous mycobacterial (NTM) lung disease. The study,…

  • Business Company News, Medical Health Aged Care
  • 31/10/2024
  • 11:03
Firebrick Pharma

Agreement Signed to Market Nasodine to Healthcare Professionals in Singapore

Firebrick Pharmais pleased to announce that it has executed a Marketing Representation Agreement (the “Agreement”) with Singapore-based, Innorini, trading as Innorini Life Sciences (“Innorini”). The initial term of the Agreement is one year with the option to renew for subsequent one-year terms by mutual agreement. Under the Agreement, Innorini will undertake “Marketing Services” commencing 1 November 2024. The Marketing Services comprise sampling and promotion of Nasodine® Nasal Spray (“Nasodine”) to General Practitioners (“GPs”) and hospital-based doctors and pharmacists (collectively “HCPs”) in Singapore. In addition to building awareness and support of Nasodine by HCPs, Innorini will be expected to sell Nasodine…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.